Nothing Special   »   [go: up one dir, main page]

Xiao et al., 2011 - Google Patents

On the role of low-energy electrons in the radiosensitization of DNA by gold nanoparticles

Xiao et al., 2011

View HTML
Document ID
593058672683473822
Author
Xiao F
Zheng Y
Cloutier P
He Y
Hunting D
Sanche L
Publication year
Publication venue
Nanotechnology

External Links

Snippet

Four different gold nanoparticle (GNP) preparations, including naked GNPs and GNPs coated either with thiolated undecane (SC 11 H 23), or with dithiolated diethylenetriaminepentaacetic (DTDTPA) or gadolinium (Gd) DTDTPA chelating agents …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer

Similar Documents

Publication Publication Date Title
Xiao et al. On the role of low-energy electrons in the radiosensitization of DNA by gold nanoparticles
Brun et al. Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution
Liu et al. Metal-based nanoenhancers for future radiotherapy: radiosensitizing and synergistic effects on tumor cells
Jin et al. Core–satellite mesoporous silica–gold nanotheranostics for biological stimuli triggered multimodal cancer therapy
Cheng et al. Synergistically enhancing the therapeutic effect of radiation therapy with radiation activatable and reactive oxygen species-releasing nanostructures
Rashid et al. Radiosensitization effects and ROS generation by high Z metallic nanoparticles on human colon carcinoma cell (HCT116) irradiated under 150 MeV proton beam
Taghizadeh et al. Gold nanoparticles application in liver cancer
Guo et al. Synthesis of BSA‐coated BiOI@ Bi2S3 semiconductor heterojunction nanoparticles and their applications for radio/photodynamic/photothermal synergistic therapy of tumor
Zhang et al. Magnesium silicide nanoparticles as a deoxygenation agent for cancer starvation therapy
Hariharan et al. Synthesis and characterization of doxorubicin modified ZnO/PEG nanomaterials and its photodynamic action
Huang et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy
Li et al. Au@ MnS@ ZnS core/shell/shell nanoparticles for magnetic resonance imaging and enhanced cancer radiation therapy
CA2660507C (en) Targeted nanoparticles for cancer diagnosis and treatment
US20080003183A1 (en) Nanoparticle radiosensitizers
Chen et al. A plasmon-enhanced theranostic nanoplatform for synergistic chemo-phototherapy of hypoxic tumors in the NIR-II window
KR102025743B1 (en) Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
Rajana et al. Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer
KR101670757B1 (en) Metallic nanoparticles, preparation and uses thereof
Matsumoto et al. Destruction of tumor mass by gadolinium-loaded nanoparticles irradiated with monochromatic X-rays: Implications for the Auger therapy
Zheng et al. Metal nanoparticles as novel agents for lung cancer diagnosis and therapy
Aldahhan et al. Emerging trends in the application of gold nanoformulations in colon cancer diagnosis and treatment
Pulagam et al. In vivo evaluation of multifunctional gold nanorods for boron neutron capture and photothermal therapies
Hlapisi et al. Encapsulation of gold nanorods with porphyrins for the potential treatment of cancer and bacterial diseases: A critical review
Amini et al. Gold cluster encapsulated liposomes: theranostic agent with stimulus triggered release capability
Titus et al. Current scenario of biomedical aspect of metal-based nanoparticles on gel dosimetry